DUBLIN--(BUSINESS WIRE)--The "Global and Chinese Embolic protection systems Industry, 2018 Market Research Report" report has been added to ResearchAndMarkets.com's offering. This report provides key ...

DUBLIN--(BUSINESS WIRE)--The "Embolic Protection Devices Market by Type (Distal Filter, Distal Occlusion, Proximal Occlusion), Material (Nitinol, Polyurethane ...

Natick, MA - Boston Scientific Corporation has agreed to acquire Embolic Protection, Inc (EPI) for $75 million in cash plus additional undisclosed payments contingent on performance milestones by EPI, ...

CHICAGO, IL—Cerebral embolic protection devices are infrequently used during transcatheter aortic valve implantation procedures in the United States, and new data suggest their use does not appear to ...

SAN FRANCISCO (MarketWatch) -- Boston Scientific Corp. on Monday said two studies showed a composite 98.1% procedural success rate by its second-generation FilterWire EZ Embolic Protection System in ...

Please provide your email address to receive an email when new articles are posted on . How many randomized clinical trials of parachutes vs. no parachutes are there? The answer, of course, is none.

Austin, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Embolic Protection Devices Market Size and Growth Analysis: According to SNS Insider, the global Embolic Protection Devices Market was valued at USD 656.60 ...

A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...

For patients who have soft, lipid-rich carotid plaques that are prone to prolapse during stent implantation, combining proximal embolic protection with newer double-layer stents reduces the risk of ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — In PROTECTED TAVR, the largest-ever randomized trial of transcatheter aortic valve replacement, ...